Investing.com - bioAffinity Technologies (NASDAQ: BIAF) reported fourth quarter EPS of $-0.19, in line with the analyst estimate of $-0.19. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
bioAffinity Technologies's stock price closed at $1.83. It is up 6.40% in the last 3 months and up 0.00% in the last 12 months.
bioAffinity Technologies saw positive EPS revisions and negative EPS revisions in the last 90 days. See bioAffinity Technologies's stock price’s past reactions to earnings here.
According to InvestingPro, bioAffinity Technologies's Financial Health score is "weak performance".
Check out bioAffinity Technologies's recent earnings performance, and bioAffinity Technologies's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar